[go: up one dir, main page]

NO20004089L - Nye triazolo(4,5-d)pyrimidinforbindelser - Google Patents

Nye triazolo(4,5-d)pyrimidinforbindelser

Info

Publication number
NO20004089L
NO20004089L NO20004089A NO20004089A NO20004089L NO 20004089 L NO20004089 L NO 20004089L NO 20004089 A NO20004089 A NO 20004089A NO 20004089 A NO20004089 A NO 20004089A NO 20004089 L NO20004089 L NO 20004089L
Authority
NO
Norway
Prior art keywords
pyrimidine compounds
new triazolo
triazolo
new
pyrimidine
Prior art date
Application number
NO20004089A
Other languages
English (en)
Norwegian (no)
Other versions
NO20004089D0 (no
Inventor
Roger Brown
Garry Pairaudeau
Brian Springthorpe
Stephen Thom
Paul Willis
Original Assignee
Astrazeneca Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9800458A external-priority patent/SE9800458D0/xx
Priority claimed from SE9803669A external-priority patent/SE9803669D0/xx
Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd
Publication of NO20004089D0 publication Critical patent/NO20004089D0/no
Publication of NO20004089L publication Critical patent/NO20004089L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20004089A 1998-02-17 2000-08-16 Nye triazolo(4,5-d)pyrimidinforbindelser NO20004089L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9800458A SE9800458D0 (sv) 1998-02-17 1998-02-17 Novel compounds
SE9803669A SE9803669D0 (sv) 1998-10-26 1998-10-26 Novel compounds
PCT/SE1999/000154 WO1999041254A1 (fr) 1998-02-17 1999-02-05 Nouveaux composes de triazolo[4,5-d] pyrimidine

Publications (2)

Publication Number Publication Date
NO20004089D0 NO20004089D0 (no) 2000-08-16
NO20004089L true NO20004089L (no) 2000-10-16

Family

ID=26663214

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004089A NO20004089L (no) 1998-02-17 2000-08-16 Nye triazolo(4,5-d)pyrimidinforbindelser

Country Status (21)

Country Link
US (1) US6369064B1 (fr)
EP (1) EP1056749B1 (fr)
JP (1) JP2002503663A (fr)
KR (1) KR20010078696A (fr)
CN (1) CN1291193A (fr)
AR (1) AR015515A1 (fr)
AT (1) ATE232866T1 (fr)
AU (1) AU2650099A (fr)
BR (1) BR9907934A (fr)
CA (1) CA2316264A1 (fr)
DE (1) DE69905451T2 (fr)
HU (1) HUP0100328A3 (fr)
ID (1) ID27127A (fr)
IL (1) IL137812A0 (fr)
MX (1) MXPA00007634A (fr)
NO (1) NO20004089L (fr)
NZ (1) NZ505250A (fr)
PL (1) PL342430A1 (fr)
SK (1) SK12242000A3 (fr)
TR (1) TR200002380T2 (fr)
WO (1) WO1999041254A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702773D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds
SE9904129D0 (sv) * 1999-11-15 1999-11-15 Astra Pharma Prod Novel compounds
GB0013488D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Chemical compound
AR028110A1 (es) * 2000-06-02 2003-04-23 Astrazeneca Ab Nuevo proceso
US7086397B2 (en) * 2002-02-16 2006-08-08 Graham Lindley Spruiell Patient usable emergency medical kit
GB0219746D0 (en) * 2002-08-23 2002-10-02 Inst Of Ex Botany Ascr Azapurine derivatives
US7335648B2 (en) 2003-10-21 2008-02-26 Inspire Pharmaceuticals, Inc. Non-nucleotide composition and method for inhibiting platelet aggregation
US7749981B2 (en) * 2003-10-21 2010-07-06 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
US7504497B2 (en) * 2003-10-21 2009-03-17 Inspire Pharmaceuticals, Inc. Orally bioavailable compounds and methods for inhibiting platelet aggregation
EP1685135B1 (fr) 2003-10-21 2010-05-26 Inspire Pharmaceuticals, Inc. COMPOSES TETRAHYDRO-FURO[3,4-d]DIOXOLE, ET COMPOSITIONS ET PROCEDE POUR INHIBER UNE AGREGATION PLAQUETTAIRE
US7932376B2 (en) 2005-05-05 2011-04-26 Inspire Pharmaceuticals, Inc. Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
WO2007020935A1 (fr) * 2005-08-17 2007-02-22 Ono Pharmaceutical Co., Ltd. Agent thérapeutique pour soulager la douleur, comprenant un récepteur p2y12 et/ou un bloqueur de récepteur p2y14
WO2008054795A2 (fr) 2006-10-31 2008-05-08 Janssen Pharmaceutica, N.V. Dérivés de triazolopyrimidine convenant comme antagonistes du récepteur p2y12 de l'adp
ES2558843T3 (es) * 2008-09-09 2016-02-09 Astrazeneca Ab Procedimiento para preparar [1S-[1-alfa,2-alfa,3-beta(1S*,2R*),5-beta]]-3-[7-[2-(3,4-difluorofenil)-ciclopropilamino]-5-(propiltio)-3H-1,2,3-triazolo[4,5-d]pirimidin-3-il]-5-(2-hidroxietoxi)ciclopentano-1,2-diol y a sus productos intermedios
WO2015027431A1 (fr) 2013-08-29 2015-03-05 Merck Sharp & Dohme Corp. Antagonistes 2,2-difluorodioxolo du récepteur a2a
WO2015162630A1 (fr) * 2014-04-25 2015-10-29 Anlon Chemical Research Organization Nouveaux procédés de préparation de triazolo[4,5-d]-pyrimidines, dont le ticagrelor, via de nouveaux intermédiaires et une nouvelle voie de synthèse
LT3433234T (lt) 2016-03-22 2021-12-10 Merck Sharp & Dohme Corp. Nikotino acetilcholino receptorių alosteriniai moduliatoriai
CN111116592A (zh) * 2019-11-27 2020-05-08 杭州沧海帆医药科技有限公司 嘧啶并三氮唑类化合物及其医药用途
CN112876485A (zh) * 2021-01-25 2021-06-01 郭丽伟 一种用于治疗子宫平滑肌高频率强直性收缩相关疾病的化合物
US20250017936A1 (en) * 2021-11-22 2025-01-16 Purdue Research Foundation Cell-potent bisubstrate inhibitors for nicotinamide n-methyltransferase (nnmt) and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742064A (en) 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
GB8826205D0 (en) 1988-11-09 1988-12-14 Wellcome Found Heterocyclic compounds
EP0840740B1 (fr) * 1995-07-11 2002-05-02 AstraZeneca AB Nouveaux inhibiteurs de l'agregation plaquettaire
JP4125790B2 (ja) * 1996-12-20 2008-07-30 アストラゼネカ・アクチエボラーグ トリアゾロ［４，５−ｄ］ピリミジニル誘導体および医薬としてのその使用
SE9702774D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds
SE9702772D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds

Also Published As

Publication number Publication date
CN1291193A (zh) 2001-04-11
AR015515A1 (es) 2001-05-02
PL342430A1 (en) 2001-06-04
JP2002503663A (ja) 2002-02-05
HUP0100328A2 (hu) 2001-09-28
ATE232866T1 (de) 2003-03-15
NO20004089D0 (no) 2000-08-16
CA2316264A1 (fr) 1999-08-19
BR9907934A (pt) 2000-10-24
WO1999041254A1 (fr) 1999-08-19
EP1056749B1 (fr) 2003-02-19
SK12242000A3 (sk) 2001-03-12
HUP0100328A3 (en) 2003-04-28
EP1056749A1 (fr) 2000-12-06
DE69905451T2 (de) 2003-11-20
ID27127A (id) 2001-03-01
AU2650099A (en) 1999-08-30
US6369064B1 (en) 2002-04-09
NZ505250A (en) 2002-10-25
IL137812A0 (en) 2001-10-31
MXPA00007634A (es) 2003-09-10
TR200002380T2 (tr) 2001-03-21
DE69905451D1 (de) 2003-03-27
KR20010078696A (ko) 2001-08-21

Similar Documents

Publication Publication Date Title
NO20004089L (no) Nye triazolo(4,5-d)pyrimidinforbindelser
NO20000311L (no) Nye forbindelser
NO20000313L (no) Nye forbindelser
UA66801C2 (uk) Триазоло[4,5-d]піримідинові сполуки, спосіб їх одержання (варіанти), фармацевтична композиція на їх основі та спосіб лікування порушень агрегації тромбоцитів
AU2002305143A1 (en) Pyrazolo'1,5-a!pyridine derivatives
NO992821L (no) Ketobenzamider som calpain-inhibitorer
MY140674A (en) New crystalline form of a triazolo(4,5-d)pyrimidine compound
AU2002239344A1 (en) Pyrazolopyridines
NO20050668L (no) 7,8,9,10-tetrahydro-6H-azepino6,7,8,9-tetrahydro-pyrido og 2,3-dihydro-2H-pyrrolo [2,1-B]-kinazolinon-derivater
NO20020391L (no) 8-Fenyl-6,9-dihydro-[1,2,4]-triazolo [3,4-i]-purin-5-on- derivater
NO20055092L (no) Substituerte pyrimidioner
NO20050635L (no) Nye tricykliske spiropiperidiner eller spiropyrrolidiner
BR9714377B1 (pt) compostos derivados de 3-tiocarbamoilpirazol, seus processos de preparaÇço, uso, assim como pesticidas contendo referidos compostos.
NO20044599L (no) 3-amino-tieno[2,3-b]pyridin-2-karboksysyreamid-forbindelser og fremgangsmater for fremstilling og anvendelser av dem
IL158667A0 (en) Imidazo [1,2-a] pyridine derivatives for the prophylaxis and treatment of herpes viral infections
AU2003228770A1 (en) Substituted pyrazolopyrimidines
AU2002239348A1 (en) Pyrazolopyridine derivatives
NO993027L (no) Pyrrolo[3,4-D]pyrimidinonderivater og deres anvendelse som legemidler
SE9904129D0 (sv) Novel compounds
EP1228072A4 (fr) Composes pdgf inhibiteurs du recepteur de kinase, leur preparation et leur purification, et compositions pharmaceutiques a base de ceux-ci
BRPI0210746B8 (pt) derivados de 6-'2-(fosfonometóxi)alcóxi-pirimidina e seu método de preparação
SE9802574D0 (sv) Novel compounds
NO20023001L (no) Substituerte piperazinderivater som MTP inhibitorer
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
SE9904128D0 (sv) Novel compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application